Prevalence, clinical staging and risk for blood-borne transmission of Chagas disease among Latin American migrants in Geneva, Switzerland.
about
Chagas disease among the Latin American adult population attending in a primary care center in Barcelona, SpainChagas disease: "the new HIV/AIDS of the Americas"Control and management of congenital Chagas disease in Europe and other non-endemic countries: current policies and practicesChagas disease and transfusion medicine: a perspective from non-endemic countriesRisk Factors and Screening for Trypanosoma cruzi Infection of Dutch Blood DonorsValidation of a rapid immunochromatographic assay for diagnosis of Trypanosoma cruzi infection among Latin-American Migrants in Geneva, SwitzerlandSeroprevalence of Chagas infection in the donor population.Health policies to control Chagas disease transmission in European countries.Serological and parasitological response in chronic Chagas patients 3 years after nifurtimox treatmentPrevalence of Chagas disease in Latin-American migrants living in Europe: a systematic review and meta-analysis.Usefulness of real time PCR to quantify parasite load in serum samples from chronic Chagas disease patients.First Documented Transmission of Trypanosoma cruzi Infection through Blood Transfusion in a Child with Sickle-Cell Disease in Belgium.Interdisciplinary approach at the primary healthcare level for Bolivian immigrants with Chagas disease in the city of São Paulo.Reactivation of Chagas disease after a bone marrow transplant in Italy: first case report.Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas diseasePrevalence of chronic infections and susceptibility to measles and varicella-zoster virus in Latin American immigrantsDetection and Quantification of Viable and Nonviable Trypanosoma cruzi Parasites by a Propidium Monoazide Real-Time Polymerase Chain Reaction Assay.Serological based monitoring of a cohort of patients with chronic Chagas disease treated with benznidazole in a highly endemic area of northern ArgentinaSelective Testing of At-Risk Blood Donors for Trypanosoma cruzi and Plasmodium spp. in Switzerland.A global systematic review of Chagas disease prevalence among migrants.Cross-sectional, descriptive study of Chagas disease among citizens of Bolivian origin living in Munich, Germany.Therapy of vector-borne protozoan infections in nonendemic settings.Epidemiology of Chagas disease in Europe: many calculations, little knowledge.A Case of Possible Chagas Transmission by Blood Transfusion in SwitzerlandScientific authorships and collaboration network analysis on Chagas disease: papers indexed in PubMed (1940-2009).The early implementation of Trypanosoma cruzi antibody screening of donors and donations within England: preempting a problem.Participation of TLR2 and TLR4 in Cytokines Production by Patients with Symptomatic and Asymptomatic Chronic Chagas Disease.Chagas Disease in a Non-endemic Country: A Multidisciplinary Research, Bologna, Italy.P-glycoprotein efflux pump plays an important role in Trypanosoma cruzi drug resistance.Early molecular diagnosis of acute Chagas disease after transplantation with organs from Trypanosoma cruzi-infected donors.Chagas disease: are we there yet?Chagas disease in Australia and New Zealand: risks and needs for public health interventions.Metabolic, mental health, behavioural and socioeconomic characteristics of migrants with Chagas disease in a non-endemic country.Chagas disease and systemic autoimmune diseases among Bolivian patients in Switzerland.Serological evaluation for Chagas disease in migrants from Latin American countries resident in Rome, Italy.Skin lesions, malaise, and heart failure in a renal transplant recipient.Recombinant Enolase of Trypanosoma cruzi as a Novel Vaccine Candidate against Chagas Disease in a Mouse Model of Acute Infection.Congenital Chagas Disease in the United States: Cost Savings through Maternal ScreeningGlobalization of Chagas Disease: A Growing Concern in Nonendemic CountriesLimited infant exposure to benznidazole through breast milk during maternal treatment for Chagas disease
P2860
Q21092283-4E032252-FF92-41A1-9069-DBC58CA2A349Q21144502-04FA34FA-8E3F-49E0-9385-4F3E6E1E82FFQ26765133-C8500C8C-FFE9-4D85-8D4E-972A1D38E50EQ26777968-5C21A5FA-764E-4D03-BCC5-3584874F4B39Q29353622-47E3B8CD-9780-4489-9700-CAE345BF5ACFQ34046216-C7AD5C45-425A-4C0C-A239-5DEDC6C33D3EQ34364999-1DD06544-80DF-4C34-8056-82C6CB280701Q34428069-D1F5BF2B-58E9-46A1-A399-588B23D9CDECQ34584940-481F0C09-07E9-4204-8229-25F673F96F4FQ35095569-AD4B13AB-6D7F-482F-A62F-97011C0FA73FQ35204314-5FD0D823-F477-434C-AEB8-CE7EE379A1C8Q35808368-3CA1F09B-27B1-452C-A2EC-6F8FC48E8696Q36319603-CCA46D7E-2054-4E2D-B1E8-437C70476419Q36393521-C7B16B9F-A40B-45AC-87E6-35035B5EF6E1Q36668496-397903AE-5F72-4359-B7A1-AC3AB1CCF58DQ36890565-C4AFF038-C6B4-407D-876D-175D493E3ED4Q36958490-E515D918-A9C4-44F9-9056-7F4FD611B9DFQ37007518-3B3F6632-9218-4285-B5D1-0B04ED4F07FAQ37045828-DCB63FEC-C847-4A81-BF79-8AC59A774AEEQ37502613-74F95264-BFF7-4851-9F2B-AFA17E13F6E1Q37598346-57D3F497-0B2D-4629-A911-945F2EE56D74Q37879203-47A8155C-7AA1-47CE-8FE6-DC71E2395F1FQ38132635-AC5D9815-AD7E-4CC6-B4F4-3D5B8724F35BQ38376720-5A4E3735-133B-44FD-B40E-6F90739FE201Q39027963-CEF76B17-71BE-44AC-968E-C8C63353CCB1Q39139718-CF2A57EC-649F-4387-8D4F-FD27FD538B9CQ39244146-48E34153-FDE1-4A1C-A7B0-313597468BB7Q40984422-2EA69FAB-4F20-453D-8563-DB12124713F2Q41038675-2FBD8511-6595-4162-860E-5A760B89D278Q42239658-628ECF81-EA07-4D81-8E3C-56F2EE1B729AQ43198132-C3B76A87-D74D-4571-B557-3029DEA53A02Q43412051-63AE1700-84C6-40F4-BD14-7327AC8E7CB1Q48701926-1C406FE7-E372-4023-BCFB-E8778D880B64Q50142226-274F7A96-F6D5-4B46-93E3-F569944361BCQ54217936-8CA27F8C-D770-4119-ACD4-E50F31A1A4EFQ54315597-97CEFC88-478A-4F73-958C-F397810C62B8Q55226818-A3952A7C-5345-4E68-AB44-1C2990377079Q56379050-74506A4C-450C-4CD2-91DD-827A315395CDQ58701342-619B761D-09C3-47D1-9063-79B151C088BBQ58862886-A62FCF6D-7B8E-4B24-9C5E-038EB648B254
P2860
Prevalence, clinical staging and risk for blood-borne transmission of Chagas disease among Latin American migrants in Geneva, Switzerland.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prevalence, clinical staging a ...... grants in Geneva, Switzerland.
@ast
Prevalence, clinical staging a ...... grants in Geneva, Switzerland.
@en
Prevalence, clinical staging a ...... grants in Geneva, Switzerland.
@nl
type
label
Prevalence, clinical staging a ...... grants in Geneva, Switzerland.
@ast
Prevalence, clinical staging a ...... grants in Geneva, Switzerland.
@en
Prevalence, clinical staging a ...... grants in Geneva, Switzerland.
@nl
prefLabel
Prevalence, clinical staging a ...... grants in Geneva, Switzerland.
@ast
Prevalence, clinical staging a ...... grants in Geneva, Switzerland.
@en
Prevalence, clinical staging a ...... grants in Geneva, Switzerland.
@nl
P2093
P2860
P50
P1476
Prevalence, clinical staging a ...... grants in Geneva, Switzerland.
@en
P2093
Aglaé Tardin
Alejandro Luquetti
Anne Mauris
Jean Jannin
Jean-Michel Gaspoz
Juan Sztajzel
Louis Loutan
Marylise Holst
Pedro Albajar Vinas
Valérie Besse
P2860
P356
10.1371/JOURNAL.PNTD.0000592
P407
P5008
P577
2010-02-02T00:00:00Z